San Diego-based Cradle Genomics, a provider of a prenatal testing methodology, has secured $17.1 million in funding. Illumina Ventures and Section 32 led the round with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Listwin Ventures and Axon Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: